Dr Thomas Bachelot
- Specialty
- Oncologist, breast and gynecology expert
- Title
- Assistant department coordinator
- Hospital
- Centre Léon Bérard (Lyon)
- Latest articles
-
- Clinical features associated with exceptional response on first-line anti-HER2-based therapy for metastatic breast cancer: real-world data from the ESME national cohort. (Oct 13, 2026)
- Prediction of benefit from docetaxel chemotherapy for HR-positive breast cancer in the PACS-01 trial. (Oct 1, 2026)
- Tucatinib, trastuzumab, and capecitabine as second- or third-line therapy after trastuzumab deruxtecan in HER2-positive metastatic breast cancer: A multicenter retrospective study in France. (Sep 29, 2026)
- Chemotherapy outcomes in human epidermal growth factor receptor 2-low, hormone receptor-positive metastatic breast cancer: Insights from the French multicenter ESME database. (Sep 27, 2026)
- Characteristics and outcomes of patients with HER2-negative metastatic breast cancers with low expression of estrogen and progesterone receptors in the multicenter ESME cohort. (Aug 1, 2026)